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Background
Unfractionated heparin (UFH) is mostly obtained from
porcine and bovine mucosa and has been widely used for
the treatment and prevention of thrombotic events. It con-
sists of molecular chains of various lengths varying from
2000 to 40,000 Da [1]. Low molecular weight heparins
(LMWHs) are smaller chains of UFH that can be obtained,
from unfractionated heparin, by various chemical and
enzymatic depolymerization processes and since they are
produced from natural heparin, they must share structural
and functional features with the parent compound, how-
ever, the depolymerization process used for their produc-
tion leads to unique structural and functional characters.
Apart from its noble anticoagulant properties, heparin and
its derivatives can interact and modulate proteins involved
in different biological process such as inflammation [2]
and angiogenesis [3]; yet, its mechanism of action are still
under debate. Furthermore, heparin broader use is still
impaired due to its strong anticoagulant activity and
hemorrhagic complications.
Methods
Employing several physical-chemical analyses, nuclear
magnetic resonance spectroscopy, scanning ultraviolet
spectroscopy, circular dichroism and chromatographic
techniques, coupled to various in vivo and in vitro biologi-
cal and functional assays, our laboratory has been, for sev-
eral decades, in the forefront of heparin and heparin-like
structure/function studies as well as their distribution in
the animal kingdom.
Results and conclusions
Over the years we’ve shown differences in heparin struc-
ture, molecular weight and biological activities revealing a
tremendous level of variability. As a classical example, the
commercial heparins from bovine lung and bovine mucosa
differ in the amounts and content of their constituent
disaccharides [4]. A systematic study on the structure of
some mammalian and invertebrate heparins has shown
that all the heparins contain two different basic regions
that vary according to the tissue and species of origin. Low
and Ultra Low Molecular weight (ULMWHs) heparins
have also been extensively characterised, where we’ve
showed that ULMWHs are structurally related to
LMWHs; however, their saccharide composition and aver-
age molecular weight differ considerably. In general, they
possess higher levels of 3-O-sulfated glucosamine residues
and higher amounts of unsaturated uronic acid [5].
More recently, the extraction, structural characterization
and activity of heparinoids from the Pacific White Shrimp,
L. vannamei, with repeating structures closely resembling
those of heparin, have been reported [3,4]. These heparin-
like structures, in contrast to those from mammalian
heparin, have low anticoagulant and hemorrhagic potential
but, exhibit potentially useful anti-inflammatory and anti-
angiogenic activities. Furthermore, against the general
accepted view, we’ve shown that the anticoagulant activity
of heparin derivatives are related to the conformational
stabilisation of the AT:polysaccharide complex, rather
than the induced secondary structural changes in AT. The
secondary structural changes induced by active and inac-
tive saccharides were detectable to a high degree of sensi-
tivity by synchrotron radiation circular dichroism (SRCD)
but, they did not differ significantly [6]. Altogether, we’ve
been dissecting the mechanism of action of heparin and
its derivatives, bringing shedding light on the relationship
between structure and function of this class of remarkable
important molecules.
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